Dialyzer reaction about indication sign symptoms and their management, give me in poster form
dialyzer reaction types signs symptoms management hemodialysis
mkdir -p /home/daytona/workspace/dialyzer-poster
~/dialyzer-poster/poster.js
const pptxgen = require("pptxgenjs");
const pres = new pptxgen();
pres.layout = "LAYOUT_WIDE"; // 13.3 x 7.5 inches β landscape poster
pres.title = "Dialyzer Reaction - Clinical Reference Poster";
// βββ Colour Palette ββββββββββββββββββββββββββββββββββββββββββββββββ
const NAVY = "0D2B5E"; // dominant dark background
const TEAL = "1ABC9C"; // accent green
const RED = "E74C3C"; // Type A danger
const ORANGE = "E67E22"; // Type B warning
const BLUE_CARD = "1A3A6B"; // card backgrounds
const PURPLE = "7B4FD4"; // pyrogenic / misc
const WHITE = "FFFFFF";
const LIGHT_GRAY= "D5E8F5"; // very light blue-grey text
const YELLOW = "F1C40F"; // highlight
const slide = pres.addSlide();
// βββ BACKGROUND ββββββββββββββββββββββββββββββββββββββββββββββββββββ
slide.addShape(pres.ShapeType.rect, {
x: 0, y: 0, w: 13.3, h: 7.5,
fill: { color: NAVY }
});
// βββ TOP HEADER BAR ββββββββββββββββββββββββββββββββββββββββββββββββ
slide.addShape(pres.ShapeType.rect, {
x: 0, y: 0, w: 13.3, h: 0.85,
fill: { color: TEAL }
});
// Title
slide.addText("DIALYZER REACTIONS", {
x: 0.15, y: 0.0, w: 9.0, h: 0.85,
fontSize: 30, bold: true, color: WHITE,
fontFace: "Calibri", valign: "middle", align: "left",
charSpacing: 4, margin: 0
});
// Subtitle badge
slide.addShape(pres.ShapeType.rect, {
x: 9.3, y: 0.12, w: 3.7, h: 0.6,
fill: { color: NAVY }, line: { color: WHITE, width: 1.2 },
rounding: 0.08
});
slide.addText("Indications | Signs & Symptoms | Management", {
x: 9.3, y: 0.12, w: 3.7, h: 0.6,
fontSize: 7.5, color: LIGHT_GRAY, align: "center", valign: "middle",
fontFace: "Calibri", margin: 0
});
// βββ OVERVIEW ROW (thin band) ββββββββββββββββββββββββββββββββββββββ
slide.addShape(pres.ShapeType.rect, {
x: 0, y: 0.85, w: 13.3, h: 0.42,
fill: { color: "142249" }
});
slide.addText([
{ text: "Definition: ", options: { bold: true, color: TEAL } },
{ text: "Adverse reactions occurring during haemodialysis attributed to the dialyzer membrane, sterilants, or dialysate contamination. Classified as ", options: { color: LIGHT_GRAY } },
{ text: "Type A (Anaphylactic/Anaphylactoid)", options: { bold: true, color: RED } },
{ text: " and ", options: { color: LIGHT_GRAY } },
{ text: "Type B (Mild / Complement-mediated)", options: { bold: true, color: ORANGE } },
{ text: " β plus Pyrogenic reactions.", options: { color: LIGHT_GRAY } }
], {
x: 0.2, y: 0.85, w: 12.9, h: 0.42,
fontSize: 8.5, fontFace: "Calibri", valign: "middle", margin: 0
});
// βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
// βββ TYPE A CARD βββββββββββββββββββββββββββββββββββββββββββββββββββ
// βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
const cardY = 1.32;
const cardH = 5.85;
// Card background
slide.addShape(pres.ShapeType.rect, {
x: 0.15, y: cardY, w: 4.0, h: cardH,
fill: { color: BLUE_CARD },
line: { color: RED, width: 2.5 },
shadow: { type: "outer", blur: 6, offset: 2, angle: 45, color: "000000", opacity: 0.4 }
});
// Card header
slide.addShape(pres.ShapeType.rect, {
x: 0.15, y: cardY, w: 4.0, h: 0.52,
fill: { color: RED }
});
slide.addText("β TYPE A β ANAPHYLACTIC / ANAPHYLACTOID", {
x: 0.15, y: cardY, w: 4.0, h: 0.52,
fontSize: 10, bold: true, color: WHITE, align: "center", valign: "middle",
fontFace: "Calibri", margin: 0
});
// Onset badge
slide.addShape(pres.ShapeType.rect, {
x: 0.35, y: cardY + 0.58, w: 3.6, h: 0.34,
fill: { color: "3D0A0A" }, line: { color: RED, width: 0.8 }
});
slide.addText("ONSET: Within first 5β10 min of dialysis start", {
x: 0.35, y: cardY + 0.58, w: 3.6, h: 0.34,
fontSize: 8, bold: true, color: YELLOW, align: "center", valign: "middle",
fontFace: "Calibri", margin: 0
});
// Cause
slide.addText("CAUSE", {
x: 0.35, y: cardY + 1.02, w: 3.6, h: 0.26,
fontSize: 8.5, bold: true, color: TEAL, fontFace: "Calibri", valign: "middle", margin: 0
});
slide.addText([
{ text: "β’ IgE-mediated hypersensitivity to ", options: { color: LIGHT_GRAY } },
{ text: "ethylene oxide (ETO)", options: { bold: true, color: WHITE } },
{ text: " sterilant\nβ’ Complement activation via AN69 membrane\nβ’ ACE inhibitor use + AN69 (bradykinin-mediated)\nβ’ Bioincompatible cellulosic membranes", options: { color: LIGHT_GRAY } }
], {
x: 0.35, y: cardY + 1.28, w: 3.6, h: 0.85,
fontSize: 7.8, fontFace: "Calibri", valign: "top", margin: 0
});
// Signs & Symptoms
slide.addShape(pres.ShapeType.line, {
x: 0.35, y: cardY + 2.16, w: 3.6, h: 0, line: { color: RED, width: 0.8, dashType: "dash" }
});
slide.addText("SIGNS & SYMPTOMS", {
x: 0.35, y: cardY + 2.22, w: 3.6, h: 0.26,
fontSize: 8.5, bold: true, color: TEAL, fontFace: "Calibri", valign: "middle", margin: 0
});
slide.addText([
{ text: "Skin: ", options: { bold: true, color: ORANGE } },
{ text: "Pruritus, urticaria, angioedema\n", options: { color: LIGHT_GRAY } },
{ text: "Resp: ", options: { bold: true, color: ORANGE } },
{ text: "Cough, sneezing, wheezing, dyspnoea, laryngeal oedema\n", options: { color: LIGHT_GRAY } },
{ text: "GI: ", options: { bold: true, color: ORANGE } },
{ text: "Nausea, vomiting, abdominal cramps, diarrhoea\n", options: { color: LIGHT_GRAY } },
{ text: "CVS: ", options: { bold: true, color: ORANGE } },
{ text: "Hypotension β anaphylactic shock β cardiac arrest\n", options: { color: LIGHT_GRAY } },
{ text: "Other: ", options: { bold: true, color: ORANGE } },
{ text: "Fever, chills, chest pain, 'sense of impending doom'", options: { color: LIGHT_GRAY } }
], {
x: 0.35, y: cardY + 2.50, w: 3.6, h: 1.30,
fontSize: 7.6, fontFace: "Calibri", valign: "top", margin: 0
});
// Management
slide.addShape(pres.ShapeType.line, {
x: 0.35, y: cardY + 3.84, w: 3.6, h: 0, line: { color: RED, width: 0.8, dashType: "dash" }
});
slide.addText("MANAGEMENT", {
x: 0.35, y: cardY + 3.90, w: 3.6, h: 0.26,
fontSize: 8.5, bold: true, color: TEAL, fontFace: "Calibri", valign: "middle", margin: 0
});
slide.addText([
{ text: "1. STOP dialysis immediately β DO NOT return blood\n", options: { bold: true, color: RED } },
{ text: "2. Epinephrine (adrenaline) if anaphylaxis\n", options: { color: LIGHT_GRAY } },
{ text: "3. IV antihistamines (chlorpheniramine)\n", options: { color: LIGHT_GRAY } },
{ text: "4. IV corticosteroids (hydrocortisone)\n", options: { color: LIGHT_GRAY } },
{ text: "5. Oβ supplementation / airway support\n", options: { color: LIGHT_GRAY } },
{ text: "6. IV saline for hypotension\n", options: { color: LIGHT_GRAY } },
{ text: "7. Monitor vitals; escalate if unresponsive", options: { color: LIGHT_GRAY } }
], {
x: 0.35, y: cardY + 4.18, w: 3.6, h: 1.25,
fontSize: 7.6, fontFace: "Calibri", valign: "top", margin: 0
});
// βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
// βββ TYPE B CARD βββββββββββββββββββββββββββββββββββββββββββββββββββ
// βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
const bX = 4.35;
slide.addShape(pres.ShapeType.rect, {
x: bX, y: cardY, w: 4.0, h: cardH,
fill: { color: BLUE_CARD },
line: { color: ORANGE, width: 2.5 },
shadow: { type: "outer", blur: 6, offset: 2, angle: 45, color: "000000", opacity: 0.4 }
});
slide.addShape(pres.ShapeType.rect, {
x: bX, y: cardY, w: 4.0, h: 0.52,
fill: { color: ORANGE }
});
slide.addText("β‘ TYPE B β MILD / COMPLEMENT-MEDIATED", {
x: bX, y: cardY, w: 4.0, h: 0.52,
fontSize: 10, bold: true, color: WHITE, align: "center", valign: "middle",
fontFace: "Calibri", margin: 0
});
// Onset badge
slide.addShape(pres.ShapeType.rect, {
x: bX + 0.2, y: cardY + 0.58, w: 3.6, h: 0.34,
fill: { color: "3D1A00" }, line: { color: ORANGE, width: 0.8 }
});
slide.addText("ONSET: 15β30 min after dialysis start", {
x: bX + 0.2, y: cardY + 0.58, w: 3.6, h: 0.34,
fontSize: 8, bold: true, color: YELLOW, align: "center", valign: "middle",
fontFace: "Calibri", margin: 0
});
// Cause
slide.addText("CAUSE", {
x: bX + 0.2, y: cardY + 1.02, w: 3.6, h: 0.26,
fontSize: 8.5, bold: true, color: TEAL, fontFace: "Calibri", valign: "middle", margin: 0
});
slide.addText([
{ text: "β’ Complement activation by dialyzer membrane\n", options: { color: LIGHT_GRAY } },
{ text: "β’ C3a & C5a anaphylatoxins generated\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Pulmonary leukostasis (WBC aggregation)\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Unsubstituted cellulosic membranes (first use)\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Cytokine release (less immunologic than Type A)", options: { color: LIGHT_GRAY } }
], {
x: bX + 0.2, y: cardY + 1.28, w: 3.6, h: 0.85,
fontSize: 7.8, fontFace: "Calibri", valign: "top", margin: 0
});
// S&S
slide.addShape(pres.ShapeType.line, {
x: bX + 0.2, y: cardY + 2.16, w: 3.6, h: 0, line: { color: ORANGE, width: 0.8, dashType: "dash" }
});
slide.addText("SIGNS & SYMPTOMS", {
x: bX + 0.2, y: cardY + 2.22, w: 3.6, h: 0.26,
fontSize: 8.5, bold: true, color: TEAL, fontFace: "Calibri", valign: "middle", margin: 0
});
slide.addText([
{ text: "β’ Chest pain / discomfort\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Back pain (mildβmoderate)\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Dyspnoea (pulmonary leukostasis)\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Nausea & vomiting\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Mild hypotension (less common)\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Symptoms usually resolve spontaneously", options: { bold: true, color: YELLOW } }
], {
x: bX + 0.2, y: cardY + 2.50, w: 3.6, h: 1.10,
fontSize: 7.8, fontFace: "Calibri", valign: "top", margin: 0
});
// Management
slide.addShape(pres.ShapeType.line, {
x: bX + 0.2, y: cardY + 3.64, w: 3.6, h: 0, line: { color: ORANGE, width: 0.8, dashType: "dash" }
});
slide.addText("MANAGEMENT", {
x: bX + 0.2, y: cardY + 3.70, w: 3.6, h: 0.26,
fontSize: 8.5, bold: true, color: TEAL, fontFace: "Calibri", valign: "middle", margin: 0
});
slide.addText([
{ text: "1. Continue dialysis (symptoms usually abate)\n", options: { color: LIGHT_GRAY } },
{ text: "2. Supplemental Oβ\n", options: { color: LIGHT_GRAY } },
{ text: "3. Analgesics for chest/back pain (paracetamol)\n", options: { color: LIGHT_GRAY } },
{ text: "4. Reduce blood flow rate\n", options: { color: LIGHT_GRAY } },
{ text: "5. Trendelenburg position if hypotensive\n", options: { color: LIGHT_GRAY } },
{ text: "6. Switch to synthetic high-flux membrane\n", options: { color: LIGHT_GRAY } },
{ text: "7. Reprocessed / substituted cellulosic dialyzer on next session", options: { color: LIGHT_GRAY } }
], {
x: bX + 0.2, y: cardY + 3.98, w: 3.6, h: 1.30,
fontSize: 7.6, fontFace: "Calibri", valign: "top", margin: 0
});
// βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
// βββ PYROGENIC / MISC CARD βββββββββββββββββββββββββββββββββββββββββ
// βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
const cX = 8.55;
slide.addShape(pres.ShapeType.rect, {
x: cX, y: cardY, w: 4.6, h: cardH,
fill: { color: BLUE_CARD },
line: { color: PURPLE, width: 2.5 },
shadow: { type: "outer", blur: 6, offset: 2, angle: 45, color: "000000", opacity: 0.4 }
});
slide.addShape(pres.ShapeType.rect, {
x: cX, y: cardY, w: 4.6, h: 0.52,
fill: { color: PURPLE }
});
slide.addText("π‘ PYROGENIC REACTIONS & PREVENTION", {
x: cX, y: cardY, w: 4.6, h: 0.52,
fontSize: 10, bold: true, color: WHITE, align: "center", valign: "middle",
fontFace: "Calibri", margin: 0
});
// Pyrogenic section
slide.addText("PYROGENIC REACTION", {
x: cX + 0.2, y: cardY + 0.60, w: 4.2, h: 0.26,
fontSize: 8.5, bold: true, color: TEAL, fontFace: "Calibri", valign: "middle", margin: 0
});
slide.addText([
{ text: "Cause: ", options: { bold: true, color: ORANGE } },
{ text: "Endotoxin fragments crossing dialyzer membrane from contaminated dialysate/water β cytokine release\n", options: { color: LIGHT_GRAY } },
{ text: "Signs: ", options: { bold: true, color: ORANGE } },
{ text: "Fever, chills, rigors, headache, hypotension (in severe cases)\n", options: { color: LIGHT_GRAY } },
{ text: "Rx: ", options: { bold: true, color: ORANGE } },
{ text: "Assess haemodynamic stability β’ IV fluids if hypotensive β’ Stop ultrafiltration β’ Discontinue dialysis β’ Blood cultures if infective source suspected β’ Antipyretics", options: { color: LIGHT_GRAY } }
], {
x: cX + 0.2, y: cardY + 0.90, w: 4.2, h: 1.15,
fontSize: 7.6, fontFace: "Calibri", valign: "top", margin: 0
});
// Divider
slide.addShape(pres.ShapeType.line, {
x: cX + 0.2, y: cardY + 2.10, w: 4.2, h: 0, line: { color: PURPLE, width: 0.8, dashType: "dash" }
});
// Prevention
slide.addText("PREVENTION STRATEGIES", {
x: cX + 0.2, y: cardY + 2.18, w: 4.2, h: 0.26,
fontSize: 8.5, bold: true, color: TEAL, fontFace: "Calibri", valign: "middle", margin: 0
});
slide.addText([
{ text: "Type A Prevention:\n", options: { bold: true, color: RED } },
{ text: "β’ Rinse dialyzer thoroughly before first use (remove ETO)\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Use gamma-ray or steam-sterilized dialyzers (avoid ETO)\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Avoid unmodified AN69 in patients on ACE inhibitors\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Patch-test sensitised patients\n\n", options: { color: LIGHT_GRAY } },
{ text: "Type B Prevention:\n", options: { bold: true, color: ORANGE } },
{ text: "β’ Use synthetic high-flux membranes (polysulfone, polyamide)\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Automated dialyzer reprocessing / re-use\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Avoid cellulosic membranes on first use\n\n", options: { color: LIGHT_GRAY } },
{ text: "Pyrogenic Prevention:\n", options: { bold: true, color: PURPLE } },
{ text: "β’ Use ultrapure, endotoxin-free water & dialysate\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Regular microbial monitoring of water system\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Avoid contaminated bicarbonate dialysate\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Proper CVC care; avoid infected AV fistula cannulation", options: { color: LIGHT_GRAY } }
], {
x: cX + 0.2, y: cardY + 2.46, w: 4.2, h: 2.55,
fontSize: 7.6, fontFace: "Calibri", valign: "top", margin: 0
});
// Divider
slide.addShape(pres.ShapeType.line, {
x: cX + 0.2, y: cardY + 5.06, w: 4.2, h: 0, line: { color: PURPLE, width: 0.8, dashType: "dash" }
});
// Drug-induced note
slide.addText("DRUG-INDUCED REACTIONS (Note)", {
x: cX + 0.2, y: cardY + 5.14, w: 4.2, h: 0.24,
fontSize: 8.5, bold: true, color: TEAL, fontFace: "Calibri", valign: "middle", margin: 0
});
slide.addText([
{ text: "β’ Iron dextran: ", options: { bold: true, color: YELLOW } },
{ text: "Anaphylactoid in 0.6β1% (high MW > low MW). Keep resuscitation ready.\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Heparin: ", options: { bold: true, color: YELLOW } },
{ text: "Rare hypersensitivity β switch formulation (porkβbeef) or use LMWH\n", options: { color: LIGHT_GRAY } },
{ text: "β’ Contaminated heparin: ", options: { bold: true, color: YELLOW } },
{ text: "Oversulfated chondroitin sulfate outbreak β vigilance required", options: { color: LIGHT_GRAY } }
], {
x: cX + 0.2, y: cardY + 5.40, w: 4.2, h: 0.74,
fontSize: 7.4, fontFace: "Calibri", valign: "top", margin: 0
});
// βββ COMPARISON TABLE ββββββββββββββββββββββββββββββββββββββββββββββ
// Quick comparison banner at bottom
slide.addShape(pres.ShapeType.rect, {
x: 0, y: 7.22, w: 13.3, h: 0.28,
fill: { color: "0A1E47" }
});
slide.addText([
{ text: "Sources: ", options: { bold: true, color: TEAL } },
{ text: "Harrison's Principles of Internal Medicine 22E (2025) β’ Comprehensive Clinical Nephrology 7th Ed β’ Brenner & Rector's The Kidney, 2-Vol Set", options: { color: LIGHT_GRAY } }
], {
x: 0.2, y: 7.22, w: 13.0, h: 0.28,
fontSize: 6.8, fontFace: "Calibri", valign: "middle", margin: 0
});
// βββ WRITE FILE ββββββββββββββββββββββββββββββββββββββββββββββββββββ
pres.writeFile({ fileName: "/home/daytona/workspace/dialyzer-poster/Dialyzer_Reaction_Poster.pptx" })
.then(() => console.log("Poster created successfully."))
.catch(err => console.error("Error:", err));
cd /home/daytona/workspace/dialyzer-poster && node poster.js
Dialyzer Reaction Poster
Presentation Β· PPTX
I want poster form
A professional medical educational poster about Dialyzer Reactions in hemodialysis. The poster has a dark navy blue background with three clearly separated color-coded vertical columns: LEFT COLUMN (red border) - TYPE A ANAPHYLACTIC REACTION: - Bold red header "TYPE A β ANAPHYLACTIC / ANAPHYLACTOID" - Onset badge: "Within first 5-10 minutes" - CAUSE section: IgE-mediated hypersensitivity to ethylene oxide (ETO) sterilant, AN69 membrane + ACE inhibitors, bioincompatible cellulosic membranes - SIGNS & SYMPTOMS: Skin: pruritus, urticaria, angioedema | Respiratory: wheezing, dyspnoea, laryngeal edema | GI: nausea, vomiting, abdominal cramps | CVS: hypotension β anaphylactic shock β cardiac arrest | Fever, chills, "sense of doom" - MANAGEMENT (numbered red steps): 1. STOP dialysis - DO NOT return blood 2. Epinephrine 3. IV antihistamines 4. IV corticosteroids 5. Oxygen support 6. IV saline for hypotension MIDDLE COLUMN (orange border) - TYPE B MILD REACTION: - Bold orange header "TYPE B β MILD / COMPLEMENT-MEDIATED" - Onset badge: "15β30 minutes after start" - CAUSE: Complement activation β C3a & C5a, pulmonary leukostasis, cytokine release - SIGNS & SYMPTOMS: Chest pain, back pain, dyspnoea, nausea, mild hypotension β usually self-resolving - MANAGEMENT: Continue dialysis, oxygen, analgesics, reduce blood flow, switch to synthetic high-flux membrane RIGHT COLUMN (purple border) - PYROGENIC REACTIONS & PREVENTION: - Purple header "PYROGENIC REACTIONS & PREVENTION" - Pyrogenic cause: endotoxin from contaminated dialysate - Signs: fever, chills, rigors, hypotension - Treatment steps - Prevention table comparing Type A, B, and Pyrogenic prevention strategies TOP BANNER: Teal green header "DIALYZER REACTIONS β Indications | Signs & Symptoms | Management" BOTTOM: Dark bar with source citations from Harrison's Internal Medicine and Clinical Nephrology textbooks. Clean, clinical, high contrast, bold icons for each section, white text on dark backgrounds, color-coded system throughout

| Column | Type | Colour |
|---|---|---|
| Left | Type A - Anaphylactic/Anaphylactoid | π΄ Red |
| Middle | Type B - Mild/Complement-mediated | π Orange |
| Right | Pyrogenic Reactions & Prevention | π£ Purple |
Dialyzer Reaction Poster
Presentation Β· PPTX
Summary
| Onset | First 5β10 minutes |
| Cause | IgE hypersensitivity to ethylene oxide (ETO); AN69 + ACE inhibitors |
| Symptoms | Pruritus, urticaria, wheezing, dyspnoea, abdominal cramps, hypotension β shock |
| Management | STOP dialysis, DO NOT return blood; Epinephrine + antihistamines + corticosteroids + Oβ + IV saline |
| Onset | 15β30 minutes |
| Cause | C3a/C5a complement activation; pulmonary leukostasis from cellulosic membranes |
| Symptoms | Chest pain, back pain, dyspnoea, mild nausea - usually self-resolving |
| Management | Continue dialysis; Oβ; analgesics; switch to synthetic high-flux membrane |
| Cause | Endotoxin fragments from contaminated dialysate crossing the membrane |
| Symptoms | Fever, chills, rigors, headache, hypotension |
| Management | IV fluids, stop ultrafiltration, antipyretics, blood cultures if infection suspected |
Key rule: Type A = STOP immediately. Type B = can usually continue dialysis.